NCT01836536View on ClinicalTrials.gov

Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

August 31, 2015

Conditions
GlioblastomaGlioma
Interventions
DRUG

Bevacizumab standard of care

Standard treatment associated with circulating leucocytes (blood samplings)

Trial Locations (2)

35042

Center Eugene Marquis, Rennes

93009

Hôpital Avicenne, Bobigny

All Listed Sponsors
lead

Center Eugene Marquis

OTHER

NCT01836536 - Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients | Biotech Hunter | Biotech Hunter